Selective advantage of HLA matching in successful uncomplicated oocyte donation pregnancies

J Reprod Immunol. 2015 Nov:112:29-33. doi: 10.1016/j.jri.2015.05.006. Epub 2015 Jun 23.

Abstract

Oocyte donation (OD) enables women with various causes of reproductive failure to conceive, but is accompanied by a high risk of certain pregnancy disorders. Possibly, the allogeneic nature of the fetus in OD pregnancies plays a role in the development of these disorders. In this study, we investigated whether there is a selection for some degree of HLA matching in successful and uncomplicated OD pregnancies. Mothers and children from OD pregnancies that used unrelated donors (n=75) were typed for HLA-A, -B, -C, -DR, and -DQ and the observed number of HLA matches of the child was compared with the expected number of HLA matches. Moreover, we studied the possibility of a preferential selection for maternal KIR and fetal C combinations. We observed a significantly higher level of HLA matching between mother and child than expected by chance. In particular, the incidence of children with 5 or more HLA matches, which is the situation in autologous pregnancy, was higher than expected. A higher level of matching was shown, especially for HLA class I, while no significant differences were observed for the individual HLA loci. With respect to maternal KIR and fetal HLA-C no selection for a favorable combination was found. Larger observational studies including uncomplicated, preeclamptic, and aborted pregnancies are essential to determine to what extent HLA matching affects the outcome of OD pregnancies.

Keywords: Human leukocyte antigen; KIR; Miscarriage; Mismatches; Oocyte donation; Preeclampsia.

Publication types

  • Clinical Trial

MeSH terms

  • Abortion, Spontaneous / immunology
  • Abortion, Spontaneous / prevention & control*
  • Adult
  • Donor Selection / methods*
  • Female
  • HLA Antigens / immunology*
  • Histocompatibility Testing*
  • Humans
  • Middle Aged
  • Oocyte Donation*
  • Pre-Eclampsia / immunology
  • Pre-Eclampsia / prevention & control*
  • Pregnancy
  • Unrelated Donors*

Substances

  • HLA Antigens